Translational Nanobiomaterials and Imaging (TNI) Group, Department of Radiology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
J Control Release. 2021 Oct 10;338:870-889. doi: 10.1016/j.jconrel.2021.09.001. Epub 2021 Sep 4.
Fluorine-19 (F) magnetic resonance imaging (MRI) features one of the most investigated and innovative techniques for quantitative and unambiguous cell tracking, providing information for both localization and number of cells. Because of the relative insensitivity of the MRI technique, a high number of magnetically equivalent fluorine atoms are required to gain detectable signals. However, an increased amount of F nuclei induces low solubility in aqueous solutions, making fluorine-based probes not suitable for in vivo imaging applications. In this context, nanoparticle-based platforms play a crucial role, since nanoparticles may carry a high payload of F-based contrast agents into the relevant cells or tissues, increase the imaging agents biocompatibility, and provide a highly versatile platform. In this review, we present an overview of the F-based nanoprobes for sensitive F-MRI, focusing on the main nanotechnologies employed to date, such as fluorine and theranostic nanovectors, including their design and applications.
氟-19(F)磁共振成像(MRI)是一种最受关注和创新的定量和明确细胞示踪技术,可提供细胞定位和数量的信息。由于 MRI 技术的相对不敏感性,需要大量的磁等价氟原子来获得可检测的信号。然而,增加的 F 核数量会导致在水溶液中的低溶解度,使得基于氟的探针不适合用于体内成像应用。在这种情况下,基于纳米粒子的平台起着至关重要的作用,因为纳米粒子可以将高负载的基于 F 的造影剂带入相关的细胞或组织中,提高成像剂的生物相容性,并提供一个高度通用的平台。在这篇综述中,我们介绍了用于灵敏 F-MRI 的基于 F 的纳米探针,重点介绍了迄今为止使用的主要纳米技术,如氟和治疗性纳米载体,包括它们的设计和应用。